Anil K. Singhal

Insider Reports History

Location
Westminster, CO
Signature
/s/ Jonathan Owen, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anil K. Singhal:

Company Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Director Director stock option (right to buy) 15,000 13 Aug 2024 Direct
Werewolf Therapeutics, Inc. Director Stock Option (right to buy) 8,358 12 Jun 2025 Direct

Insider Reports Filed by Anil K. Singhal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOWL Werewolf Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:10
HOWL Werewolf Therapeutics, Inc. 19 Feb 2025 1 $0 4 Director 21 Feb 2025, 17:57
HOWL Werewolf Therapeutics, Inc. 19 Feb 2025 0 $0 3 Director 21 Feb 2025, 17:54
TLSI TriSalus Life Sciences, Inc. 13 Aug 2024 1 $0 4 Director 21 Aug 2024, 20:37
TLSI TriSalus Life Sciences, Inc. 10 Aug 2023 1 $0 4 Director 14 Aug 2023, 18:03
TLSI TriSalus Life Sciences, Inc. 10 Aug 2023 0 $0 3 Director 14 Aug 2023, 18:00